| Report ID | 279913 |
| Drug Identification Number | 00037869 |
| Brand name | POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP |
| Common or Proper name | POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM CHLORIDE |
| Strength(s) | 149MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 25X10ML vial |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-04-11 |
| Actual start date | |
| Estimated end date | 2026-09-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-06 |
| Company comments | 20ml presentation remains available. Ordering restrictions will apply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-06 | French | Compare |
| v1 | 2026-03-06 | English | Compare |
Showing 1 to 2 of 2